S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)

Cocrystal Pharma (COCP) Earnings Date, Estimates & Call Transcripts

$1.44
-0.01 (-0.70%)
(As of 03:00 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

COCP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

COCP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cocrystal Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.57)($0.57)($0.57)
Q2 20241($0.58)($0.58)($0.58)
Q3 20241($0.59)($0.59)($0.59)
Q4 20241($0.60)($0.60)($0.60)
FY 20244($2.34)($2.34)($2.34)

COCP Earnings Date and Information

Cocrystal Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates.

Cocrystal Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/3/2024
Estimated)
------- 
11/13/2023Q3 2023($0.47)($0.41)+$0.06($0.41)--
8/14/2023Q2 2023($0.53)($0.50)+$0.03($0.50)--
5/15/2023Q1 2023($0.59)($0.64)($0.05)($0.64)--
3/29/2023Q4 2022($0.72)($0.55)+$0.17($0.55)--
11/14/2022Q3 2022($0.49)($0.70)($0.21)($0.70)--
8/15/2022Q2 2022($0.48)($0.48)-$0.17--
5/11/2022Q1 2022($0.48)($0.48)-($0.04)--
3/23/2022Q4 2021($0.48)($0.48)-($0.04)--
11/15/2021Q3 2021($0.48)($0.48)-($0.04)--
8/15/2021Q2 2021($0.48)($0.48)-($0.04)--
5/16/2021Q1 2021($0.48)($0.48)-($0.04)--
3/16/2021Q4($0.48)($0.12)+$0.36($0.01)$0.58 million$0.51 million












Cocrystal Pharma Earnings - Frequently Asked Questions

When is Cocrystal Pharma's earnings date?

Cocrystal Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on COCP's earnings history.

How much profit does Cocrystal Pharma generate each year?

Cocrystal Pharma (NASDAQ:COCP) has a recorded net income of -$38.84 million. COCP has generated -$2.10 earnings per share over the last four quarters.

What is Cocrystal Pharma's EPS forecast for next year?

Cocrystal Pharma's earnings are expected to grow from ($2.01) per share to ($1.91) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:COCP) was last updated on 2/23/2024 by MarketBeat.com Staff